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2DITORIAL COMMENT
oes Hospital Coronary
ntervention Volume
atter in Predicting Mortality?*
lan C. Yeung, MD
alo Alto, California
n the late 1990s, the Institute of Medicine pointed out that
he health care system in the U.S. performs far below
btainable levels of patient safety and overall values. It is
stimated that 44,000 to 98,000 Americans die each year as
result of medical errors. In 1998, the Leapfrog Group (1)
as formed by a number of large U.S. health care purchasers
o initiate breakthroughs in the safety and the overall value
f health care to U.S. consumers. One of the three initial
ethods to improve patient safety is evidence-based hospi-
al referral (2):
“One marker of how well a hospital is likely to perform is
the experience of the hospital and its surgical team. In the
absence of data to compare hospitals on their complications
and survival rates, one can begin evaluating experience by
looking at the number of high risk treatments and proce-
dures a hospital performs each year. Referrals to institutions
with a lot of experience treating certain conditions offer the
best survival odds. For example, Evidence-Based Hospital
Referral for certain conditions show strong statistical rela-
tionships between patient survival and a hospital’s annual
volume of such procedures.”
ne such procedure is percutaneous coronary intervention
PCI). Based on the guideline set by the American College
f Cardiology/American Heart Association (3), the Leap-
rog group has established a minimum institutional volume
equirement of 400 cases per year for hospitals offering PCI.
See page 1755
his volume threshold was set using the data based on
tudies published in the late 1980s and early 1990s using
alloon angioplasty as the primary technology. These stud-
es show that there is an increased mortality risk for patients
reated at hospitals with annual PCI volumes of fewer than
00 cases (4). However, with the advent of widespread
oronary stenting, the use of IIb/IIIa antagonists and oral
denosine diphosphate antagonists, PCI appears to be
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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enter, Palo Alto, California.ignificantly safer for a large range of patients. Whether the
ld volume criterion is still valid is unclear. In this issue of
he Journal, Epstein et al. (5) describe a study that evaluated
hether the current volume standard still holds in the stent
ra.
The authors studied the in-hospital mortality among
62,748 patients in the Agency for Healthcare Research and
uality National In-patient Sample hospital discharge da-
abase. The hospitals were separated into low- (5 to 199
ases/year), medium- (200 to 399 cases/year), high- (400 to
99 cases/year), and very high- (1,000 cases or more/year)
olume centers. Compared with patients treated in high-
olume hospitals, patients treated in low-volume hospitals
emained at increased risk after adjustment for patient
haracteristics. However, patients treated at medium-
olume hospitals had a similar risk as high-volume centers.
hus, is it time to change the American College of
ardiology/American Heart Association volume criteria?
Not so fast! This study (5) certainly suggests that the 400
ases/year figure may be high in the stent era, but low-
olume centers should still be concerned about quality. The
nadjusted mortality rate is 1.58, 1.12, 1.00, and 0.84
mong the hospitals with increased patient volume. After
eing adjusted for clinical variables, the difference became
maller, mainly because there is a larger proportion of
atients with myocardial infarction and smaller proportions
f elective admissions and patients who arrived by inter-
ospital transfer in the low-volume centers. However, no
ccount was taken of the angiographic characteristics or
esion complexity. It is common that large and very large
enters do indeed perform “high-risk rejects” from other
ospitals and that small-volume hospitals may not perform
CI in multivessel disease patients (5). Thus, the adjust-
ent for clinical risks may or may not mask the real
ifference between the hospitals.
The volume criteria may indeed need to be re-examined, but
areful review of patient populations is prudent. This study also
as not taken into account whether operator volume affects
utcome, especially in the low-volume centers. Thus, both
ospital volume data and operator volume probably will be
mportant if the best outcome is to be achieved.
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